Back to search

Durable responses and long-term progression-free survival observed in a phase II study of MDX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma

Steven Fischkoff, E. M. Hersh, Jeffrey S. Weber, John D. Powderly, Khuda Dad Khan
DOI: 10.1200/jco.2005.23.16_suppl.7525
Journal of Clinical Oncology

Data up to Jan 2025

Published2005
Citations50
References0
Fields
MedicineInternal medicineOncologySurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Durable responses and long-term progression-free survival observed in a phase II study of… (2005) – Journal of Clinical Oncology | Metascience Observatory Explorer